KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13 | 0.0% | 1,065 | 0.0% | 0.00% | – |
| Q1 2024 | $13 | -50.0% | 1,065 | -49.1% | 0.00% | – |
| Q4 2023 | $26 | +18.2% | 2,093 | -9.9% | 0.00% | – |
| Q3 2023 | $22 | +4.8% | 2,324 | 0.0% | 0.00% | – |
| Q2 2023 | $21 | +10.5% | 2,324 | -4.6% | 0.00% | – |
| Q1 2023 | $19 | -5.0% | 2,436 | -18.9% | 0.00% | – |
| Q4 2022 | $20 | -100.0% | 3,004 | 0.0% | 0.00% | – |
| Q3 2022 | $44,000 | +46.7% | 3,004 | 0.0% | 0.00% | – |
| Q2 2022 | $30,000 | -44.4% | 3,004 | -17.7% | 0.00% | – |
| Q1 2022 | $54,000 | – | 3,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,579,490 | $20,146,000 | 22.25% |
| Novo Holdings A/S | 2,901,927 | $22,664,000 | 2.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 322,436 | $2,518,000 | 0.96% |
| Vivo Capital, LLC | 300,325 | $2,346,000 | 0.69% |
| VHCP Management II, LLC | 221,651 | $1,635,000 | 0.67% |
| RA Capital Management | 591,070 | $4,616,000 | 0.57% |
| INTERWEST VENTURE MANAGEMENT CO | 329,942 | $2,577,000 | 0.55% |
| Eventide Asset Management | 98,100 | $766,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 21,665 | $169,000 | 0.03% |
| A.R.T. Advisors, LLC | 11,116 | $86,000 | 0.00% |